Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01344928
Other study ID # 95/180/2010
Secondary ID
Status Recruiting
Phase N/A
First received April 28, 2011
Last updated April 28, 2011

Study information

Verified date April 2011
Source Turku University Hospital
Contact n/a
Is FDA regulated No
Health authority Finland: Ethical committee of the Hospital District of the South-Western Finland
Study type Interventional

Clinical Trial Summary

The objectives of this study are to investigate the effects of short-time high-intensity interval training on tissue glucose and fat metabolism in healthy lean subjects and type 2 diabetic patients using modern and noninvasive imaging methods positron emission tomography (PET), magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS).


Recruitment information / eligibility

Status Recruiting
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 40 Years to 55 Years
Eligibility Inclusion Criteria:

The healthy patients

1. Age 40-55

2. BMI 18.5-30

3. Fasting plasma glucose less than 6.1 mmol/l

4. Normal glucose tolerance test (OGTT)

The type 2 diabetic patients:

1. Age-, sex-, and BMI-matched with the study subjects in the phase 1

2. In a good treatment balance

3. Glycated haemoglobin (HbA1c) less than 7.5 mmol/l

4. Two hours glucose value in oral glucose tolerance test (OGTT) less than 10.0 mmol/l

Exclusion Criteria:

The healthy patients

1. Blood pressure > 140/90 mmHg

2. Any chronic disease

3. Any chronic medical defect or injury which hinder/interfere everyday life

4. History of anorexia nervosa or bulimia

5. History of rest or exercise-induced asthma

6. Previous use of anabolic steroids, additives or any other substrates

7. Smoking of tobacco, taking of snuffs, or use of narcotics.

8. Significant use of alcohol

9. Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results

10. Presence of any ferromagnetic objects that would make MR imaging contraindicated

11. Current or history of regular and systematic exercise training

12. VO2max >40 ml/min/kg

The type 2 diabetic patients:

1. Any other chronic disease than diabetes

2. Blood pressure > 140/90 mmHg

3. Any chronic medical defect or injury which hinder/interfere everyday life

4. History of anorexia nervosa or bulimia

5. History of rest or exercise-induced asthma

6. Smoking of tobacco, taking of snuffs, or use of narcotics.

7. Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results

8. Presence of any ferromagnetic objects that would make MRI imaging contraindicated

9. Current or history of regular and systematic exercise training

10. VO2max >40 ml/ min/kg

Study Design

N/A


Intervention

Behavioral:
HIT exercise intervention

Aerobic exercise intervention


Locations

Country Name City State
Finland Turku PET Centre Turku

Sponsors (9)

Lead Sponsor Collaborator
Turku University Hospital Academy of Finland, European Foundation for the Study of Diabetes, Helsinki University, Ministry of Education and Culture, Finland, Orion Farmos Research Foundation, Turku PET Centre, University of Turku, Verve Research, Oulu, Finland

Country where clinical trial is conducted

Finland, 

See also
  Status Clinical Trial Phase
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1